Kusajili – Clinical trials directory

Result of your search per sponsor: Bertrand KNEBELMANN

Woman and Man Max 99 years
Bertrand KNEBELMANN Update Il y a 4 ans

Phenylbutyrate in Proteinuric Nephropathies The purpose of this study is to determine whether sodium phenylbutyrate can reduce Lcn2 urinary expression in proteinuric patients.

Country France
organs None
Specialty None

Closed trial

More information